Gene: RUSC2
Official Full Name: RUN and SH3 domain containing 2provided by HGNC
Gene Summary: This gene encodes a RUN and SH3 domain containing protein that interacts with Rab1b and Rab1-binding protein GM130. Alternatively spliced transcript variants have been observed for this gene. [provided by RefSeq, Jun 2012]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO32650 | RUSC2 Knockout cell line (HeLa) | Human | RUSC2 | 1:3~1:6 | Negative | Online Inquiry |
KO32651 | RUSC2 Knockout cell line (HCT 116) | Human | RUSC2 | 1:2~1:4 | Negative | Online Inquiry |
KO32652 | RUSC2 Knockout cell line (HEK293) | Human | RUSC2 | 1:3~1:6 | Negative | Online Inquiry |
KO32653 | RUSC2 Knockout cell line (A549) | Human | RUSC2 | 1:3~1:4 | Negative | Online Inquiry |
RUSC2 Gene Knockout Cell Lines represent a revolutionary advancement in cellular and molecular biology research by providing an innovative platform for studying gene function and cellular mechanisms. These cell lines are engineered to have the RUSC2 gene selectively disrupted, allowing researchers to investigate the downstream effects of its absence. The key mechanism of action relies on CRISPR-Cas9 technology, which introduces precise mutations into the genomic DNA, ensuring reproducibility and reliability in experimental settings.
In terms of scientific importance, RUSC2 knockout models play a crucial role in elucidating the gene's involvement in various biological processes, including cellular signaling pathways, stress responses, and overall cellular homeostasis. This product is particularly relevant to cancer research, neurobiology, and drug discovery, where understanding gene function can lead to the identification of novel therapeutic targets and biomarkers. Moreover, these cell lines can be utilized in high-throughput screening, contributing to faster and more efficient research processes in clinical applications.
What sets RUSC2 Gene Knockout Cell Lines apart from similar offerings is their high specificity and validated performance. Our product ensures that researchers are working with a well-characterized model backed by comprehensive validation studies, guaranteeing consistency across experiments. Unlike traditional methods that often yield off-target effects or variable results, our knockout lines provide a dependable tool, enhancing experimental accuracy.
The inherent value of RUSC2 Gene Knockout Cell Lines lies in their potential to drive groundbreaking discoveries in gene function and therapeutic development. Researchers and clinicians will find these cell lines indispensable for advancing knowledge in their fields, paving the way for innovative treatments and interventions. Our company, with its commitment to the highest standards in bioengineering and our extensive expertise in producing specialized biological products, continues to empower scientists with tools that push the boundaries of discovery.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.